Clinical trial
NOGA Angiogenesis Revascularization Therapy: Evaluation by RadioNuclide Imaging…
NCT00143585 · Unity Health Toronto, Other · Unknown status
Key facts
| NCT number | NCT00143585 |
|---|---|
| Title | NOGA Angiogenesis Revascularization Therapy: Evaluation by RadioNuclide Imaging - The Northern Trial |
| Official title | Multicentre, Randomized,Double Blind,Placebo Controlled Trial of Myocardial Angiogenesis Using VEGF165, Intramyocardial Gene Delivery in Patients With Severe Angina |
| Lead sponsor | Unity Health Toronto, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia |
| Intervention type | Procedure |
| Interventions | intramyocardial delivery of either VEGF165 or placebo |
| Enrollment | 120 |
| Start date | Jun 1, 2002 |
| Completion | Jun 1, 2007 |
| First posted | Sep 2, 2005 |
| Last update posted | Jul 25, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: